Home » Topics » Infection, BioWorld Science

Infection, BioWorld Science
RSS

Viral replication inhibitors patented by Gilead

Jan. 17, 2022

Machine learning approach speeds resistance identification

Jan. 17, 2022

Everest Medicines licenses global rights to EDDC's 3CL protease inhibitors to treat COVID-19

Jan. 14, 2022

RBD-PB6 RNA aptamer blocks SARS-CoV-2 entry into host cells

Jan. 14, 2022

Researchers restore front-line antibiotics' effects

Jan. 13, 2022

Novel 2-((1H-indol-3-yl)thio)-N-phenyl-acetamides as inhibitors of SARS-CoV-2 RdRp

Jan. 13, 2022

Development of haloperidol analogues as Eis inhibitors to overcome kanamycin resistance in MDR TB

Jan. 13, 2022

REVTx-99 demonstrates in vitro antiviral activity against SARS-CoV-2

Jan. 12, 2022

Discovery of novel hybrid compounds as antitubercular agents

Jan. 12, 2022

AC Immune synthesizes NLRP3 inflammasome inhibitors

Jan. 11, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...